Valbiotis SA (ALVAL.PA)

EUR 1.0

(-0.38%)

Operating Expenses Summary of Valbiotis SA

  • Valbiotis SA's latest annual operating expenses in 2023 was 9.86 Million EUR , down -19.82% from previous year.
  • Valbiotis SA's latest quarterly operating expenses in 2024 Q2 was 2.78 Million EUR , down 0.0% from previous quarter.
  • Valbiotis SA reported a annual operating expenses of 14.03 Million EUR in annual operating expenses 2022, up 37.25% from previous year.
  • Valbiotis SA reported a annual operating expenses of 10.22 Million EUR in annual operating expenses 2021, up 36.3% from previous year.
  • Valbiotis SA reported a quarterly operating expenses of 3.79 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Valbiotis SA reported a quarterly operating expenses of 11.25 Million EUR for 2023 FY, down -19.82% from previous quarter.

Annual Operating Expenses Chart of Valbiotis SA (2023 - 2015)

Historical Annual Operating Expenses of Valbiotis SA (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 9.86 Million EUR -19.82%
2022 14.03 Million EUR 37.25%
2021 10.22 Million EUR 36.3%
2020 7.5 Million EUR 22.06%
2019 6.14 Million EUR 23.88%
2018 4.96 Million EUR 109.41%
2017 2.37 Million EUR 94.58%
2016 1.21 Million EUR 31.39%
2015 927 Thousand EUR 0.0%

Peer Operating Expenses Comparison of Valbiotis SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -136.27%
ABIVAX Société Anonyme 127.37 Million EUR 92.252%
Adocia SA 15.62 Million EUR 36.855%
Aelis Farma SA 18.81 Million EUR 47.558%
Biophytis S.A. 14.33 Million EUR 31.145%
Advicenne S.A. 8.21 Million EUR -20.134%
genOway Société anonyme 16.73 Million EUR 41.039%
IntegraGen SA 5.35 Million EUR -84.381%
Medesis Pharma S.A. 1.56 Million EUR -530.78%
Neovacs S.A. 10.34 Million EUR 4.588%
NFL Biosciences SA 4.37 Million EUR -125.611%
Plant Advanced Technologies SA 2.76 Million EUR -256.945%
Quantum Genomics Société Anonyme 1.71 Million EUR -474.459%
Sensorion SA 27.05 Million EUR 63.521%
Theranexus Société Anonyme 3 Million EUR -228.421%
TME Pharma N.V. 5.49 Million EUR -79.534%
TheraVet SA 1.64 Million EUR -500.19%
Valerio Therapeutics Société anonyme 20.32 Million EUR 51.432%
DBV Technologies S.A. 89.4 Million EUR 88.962%
Genfit S.A. 54.8 Million EUR 81.992%
GeNeuro SA 14.35 Million EUR 31.261%
Innate Pharma S.A. 64.57 Million EUR 84.716%
Inventiva S.A. 120.18 Million EUR 91.789%
MaaT Pharma SA 21.59 Million EUR 54.306%
MedinCell S.A. 32.92 Million EUR 70.023%
Nanobiotix S.A. 58.92 Million EUR 83.252%
OSE Immunotherapeutics SA 23.58 Million EUR 58.163%
Poxel S.A. 28.76 Million EUR 65.691%
GenSight Biologics S.A. 32.66 Million EUR 69.783%
Transgene SA 31.23 Million EUR 68.4%
Valneva SE 134.92 Million EUR 92.686%